63 related articles for article (PubMed ID: 38730256)
21. TCF-1 maintains CD8
Wen S; Lu H; Wang D; Guo J; Dai W; Wang Z
J Leukoc Biol; 2021 Sep; 110(3):585-590. PubMed ID: 34047386
[TBL] [Abstract][Full Text] [Related]
22. Turning cold tumors into hot tumors by improving T-cell infiltration.
Liu YT; Sun ZJ
Theranostics; 2021; 11(11):5365-5386. PubMed ID: 33859752
[TBL] [Abstract][Full Text] [Related]
23. Alternative approaches to target Myc for cancer treatment.
Wang C; Zhang J; Yin J; Gan Y; Xu S; Gu Y; Huang W
Signal Transduct Target Ther; 2021 Mar; 6(1):117. PubMed ID: 33692331
[TBL] [Abstract][Full Text] [Related]
24. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
25. Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective.
Ramelyte E; Tastanova A; Balázs Z; Ignatova D; Turko P; Menzel U; Guenova E; Beisel C; Krauthammer M; Levesque MP; Dummer R
Cancer Cell; 2021 Mar; 39(3):394-406.e4. PubMed ID: 33482123
[TBL] [Abstract][Full Text] [Related]
26. Tumor-Associated Macrophages in Tumor Immunity.
Pan Y; Yu Y; Wang X; Zhang T
Front Immunol; 2020; 11():583084. PubMed ID: 33365025
[TBL] [Abstract][Full Text] [Related]
27. Head and neck squamous cell carcinoma.
Johnson DE; Burtness B; Leemans CR; Lui VWY; Bauman JE; Grandis JR
Nat Rev Dis Primers; 2020 Nov; 6(1):92. PubMed ID: 33243986
[TBL] [Abstract][Full Text] [Related]
28. MYC Instructs and Maintains Pancreatic Adenocarcinoma Phenotype.
Sodir NM; Kortlever RM; Barthet VJA; Campos T; Pellegrinet L; Kupczak S; Anastasiou P; Swigart LB; Soucek L; Arends MJ; Littlewood TD; Evan GI
Cancer Discov; 2020 Apr; 10(4):588-607. PubMed ID: 31941709
[TBL] [Abstract][Full Text] [Related]
29. Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation.
Song J; Zhuang Y; Zhu C; Meng H; Lu B; Xie B; Peng J; Li M; Yi C
Nat Chem Biol; 2020 Feb; 16(2):160-169. PubMed ID: 31819270
[TBL] [Abstract][Full Text] [Related]
30. Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4.
Wang Z; Wu VH; Allevato MM; Gilardi M; He Y; Luis Callejas-Valera J; Vitale-Cross L; Martin D; Amornphimoltham P; Mcdermott J; Yung BS; Goto Y; Molinolo AA; Sharabi AB; Cohen EEW; Chen Q; Lyons JG; Alexandrov LB; Gutkind JS
Nat Commun; 2019 Dec; 10(1):5546. PubMed ID: 31804466
[TBL] [Abstract][Full Text] [Related]
31. Assessment of DNA Epigenetic Modifications.
Yuan BF
Chem Res Toxicol; 2020 Mar; 33(3):695-708. PubMed ID: 31690070
[TBL] [Abstract][Full Text] [Related]
32. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Burtness B; Harrington KJ; Greil R; Soulières D; Tahara M; de Castro G; Psyrri A; Basté N; Neupane P; Bratland Å; Fuereder T; Hughes BGM; Mesía R; Ngamphaiboon N; Rordorf T; Wan Ishak WZ; Hong RL; González Mendoza R; Roy A; Zhang Y; Gumuscu B; Cheng JD; Jin F; Rischin D;
Lancet; 2019 Nov; 394(10212):1915-1928. PubMed ID: 31679945
[TBL] [Abstract][Full Text] [Related]
33. PD-L1 Distribution and Perspective for Cancer Immunotherapy-Blockade, Knockdown, or Inhibition.
Wu Y; Chen W; Xu ZP; Gu W
Front Immunol; 2019; 10():2022. PubMed ID: 31507611
[TBL] [Abstract][Full Text] [Related]
34. Modelling the MYC-driven normal-to-tumour switch in breast cancer.
Lourenco C; Kalkat M; Houlahan KE; De Melo J; Longo J; Done SJ; Boutros PC; Penn LZ
Dis Model Mech; 2019 Jul; 12(7):. PubMed ID: 31350286
[TBL] [Abstract][Full Text] [Related]
35. PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy.
Zamarin D; Ricca JM; Sadekova S; Oseledchyk A; Yu Y; Blumenschein WM; Wong J; Gigoux M; Merghoub T; Wolchok JD
J Clin Invest; 2018 Apr; 128(4):1413-1428. PubMed ID: 29504948
[TBL] [Abstract][Full Text] [Related]
36. Base-Resolution Mapping Reveals Distinct m
Li X; Xiong X; Zhang M; Wang K; Chen Y; Zhou J; Mao Y; Lv J; Yi D; Chen XW; Wang C; Qian SB; Yi C
Mol Cell; 2017 Dec; 68(5):993-1005.e9. PubMed ID: 29107537
[TBL] [Abstract][Full Text] [Related]
37. The m1A landscape on cytosolic and mitochondrial mRNA at single-base resolution.
Safra M; Sas-Chen A; Nir R; Winkler R; Nachshon A; Bar-Yaacov D; Erlacher M; Rossmanith W; Stern-Ginossar N; Schwartz S
Nature; 2017 Nov; 551(7679):251-255. PubMed ID: 29072297
[TBL] [Abstract][Full Text] [Related]
38. The emerging complexity of the tRNA world: mammalian tRNAs beyond protein synthesis.
Schimmel P
Nat Rev Mol Cell Biol; 2018 Jan; 19(1):45-58. PubMed ID: 28875994
[TBL] [Abstract][Full Text] [Related]
39. Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy.
Liu Z; Ravindranathan R; Kalinski P; Guo ZS; Bartlett DL
Nat Commun; 2017 Mar; 8():14754. PubMed ID: 28345650
[TBL] [Abstract][Full Text] [Related]
40. m1A Post-Transcriptional Modification in tRNAs.
Oerum S; Dégut C; Barraud P; Tisné C
Biomolecules; 2017 Feb; 7(1):. PubMed ID: 28230814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
